medigraphic.com
ISSN 1727-897X (Electronic)

2016, Number 5

<< Back Next >>

Medisur 2016; 14 (5)

Spontaneous paravesical hematoma at a single prophylactic doses of enoxaparin in Orthopedic surgery. Case report

Sánchez HCR, Saldaña IE, Rivadeneyra EL, Soto Vega E, Arroyo KJC

Language: Spanish
References: 11
Page: 573-578
PDF size: 250.98 Kb.


ABSTRACT

Spontaneous paravesical hematoma is an infrequent complication, with a few reported cases in literature. Approximately 2 % of the patients treated with prophylactic enoxoparin will have hemorrhagic complications, from which 2 0% are retroperitoneal or intracranial hematomas depending on the risk factors. For such reasons it is presented a 35 year old patient, previously healthy, who was performed to a suture of the Achilles tendon after suffering a trauma. He was administered prophylactically a single doses of enoxoparin in the immediate post surgery and 24 hours later he started to complain of pain in the right lower quadrant and dysuria. Abdominal ultrasound showed a paravesical hematoma secondary to anesthesia which caused bleeding of the vesicle walls. This report shows prophylactic exoparin may produce spontaneous paravesical hematomas associated to vesical overdistention. However it is necessary other similar reports to confirm the previous statement.


REFERENCES

  1. Auh YH, Hoon LJ, Kung S. The Extra peritoneal Pelvic. Compartments. In: Meyers MA. Dynamic Radiology of the Abdomen. 4th. ed. Barcelona: Springer Verlag Ibérica; 1995. p. 203-21.

  2. Meyers MA. Radiología dinámica del abdomen: anatomía normal y patológica. 4ta. ed. Barcelona: Springer Verlag Ibérica; 1995.

  3. Raskob GE, Hull RS, Mandel J. Low molecular weight heparin for venous thromboembolic disease. UpToDate [revista en Internet]. 2010 [ cited 23 Feb 2015 ] ; 1: [aprox. 5p]. Available from: http://www.uptodate.com/contents/low-molecular -weight-heparin-for-venous-thromboembolic-dise ase.

  4. Buitrago F, Alejandre J, Morales J. Profilaxis del tromboembolismo e indicaciones de las heparinas de bajo peso molecular en atención primaria. FMC. 2011 ; 18 (5): 281-91.

  5. Gómez J, Martínez A, García I. ¿Cuál es la técnica idónea para disminuir las complicaciones locales secundarias a la administración subcutánea de enoxaparina? Ensayo clínico aleatorizado. Enfermería Clínica. 2005 ; 15 (5): 329-34.

  6. Pineo GF. Prevention of venous thromboembolism disease in medical patients. UpToDate [revista en Internet]. 2010 [ cited 23 Feb 2015 ] ; 1: [aprox. 6p]. Available from: http://www.uptodate.com/contents/prevention-ofvenous-thromboembolic-disease-in-acutely-ill-hos pitalized-medical-adults.

  7. Álvarez D, Schiappacasse G, Castro M, Slater J. Hematoma retroperitoneal de causa infrecuente: A propósito de un caso. Rev Chil Radiol. 2012 ; 18 (3): 107-10.

  8. Alcahúd Cortés C, Iglesias Mier T, Lázaro Castaner C, Córcoles Jiménez P, González Álvarez T, Laserna Ibáñez F, et al. Administración de heparina de bajo peso molecular y aparición de complicaciones locales en pacientes de cardiología. Enferm Cardiol. 2009 ; XVI (47-48): 94-8.

  9. Álvarez C, Cerda C, Jadue A, Rojas F, Abellerira M, et al. Hematoma retroperitoneal espontáneo. Caso clínico. Rev Méd Chile. 2007 ; 135 (8): 1044-7.

  10. Gimeno V, Bosquet M, Ramírez M, Trasierra M, Arlandis S, Jiménez J. Hemorragia retroperitoneal espontánea: nuestra experiencia en los últimos 10 años. Actas Urol Esp. 2007 ; 31 (5): 521-7.

  11. Arroyo-Sánchez A, Aguirre-Mejía R. Hematoma retroperitoneal espontáneo asociado al uso de enoxaparina y aspirina. Rev Soc Peru Med Interna. 2011 ; 24 (3): 138-41




2020     |     www.medigraphic.com